Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1044

1.

Emotional Well-Being Is Impaired in Hidradenitis Suppurativa Patients.

Senthilnathan A, Kolli SS, Cardwell LA, Richardson IM, Feldman SR, Pichardo RO.

Skin Appendage Disord. 2019 Nov;5(6):366-369. doi: 10.1159/000502296. Epub 2019 Sep 10.

PMID:
31799265
2.

Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status.

Feldman SR, Zhang J, Martinez DJ, Lopez-Gonzalez L, Marchlewicz EH, Shrady G, Mendelsohn AM, Zhao Y.

J Dermatolog Treat. 2019 Dec 8:1-9. doi: 10.1080/09546634.2019.1698699. [Epub ahead of print]

PMID:
31769703
3.

A hands-off approach may be more successful in treating chronic hand eczema.

Strowd LC, Feldman SR.

Br J Dermatol. 2019 Nov 20. doi: 10.1111/bjd.18617. [Epub ahead of print] No abstract available.

PMID:
31749174
4.

Contact dermatitis: one for the books.

Su JJ, Haidari W, Hoffman MB, Feldman SR.

Dermatol Online J. 2019 Sep 15;25(9). pii: 13030/qt09f3b9p2.

PMID:
31738850
5.

Systemic contact dermatitis related to alcoholic beverage consumption.

Ramachandran V, Cline A, Summey BT, Feldman SR.

Dermatol Online J. 2019 Sep 15;25(9). pii: 13030/qt3zg853qv.

PMID:
31738848
6.

Unilateral contact dermatitis of the chest.

Ramani LT, Feldman SR.

Dermatol Online J. 2019 Oct 15;25(10). pii: 13030/qt6h61107j.

7.

The rise in subscription skin care services.

Visconti MJ, Haidari W, Feldman SR, Taylor SL.

Dermatol Online J. 2019 Oct 15;25(10). pii: 13030/qt4th6026d.

8.

Treatment Adherence and Persistence of Five Commonly Prescribed Medications for Moderate to Severe Psoriasis in a U.S. Commercially Insured Population.

Wu B, Muser E, Teeple A, Pericone CD, Feldman SR.

J Dermatolog Treat. 2019 Nov 12:1-26. doi: 10.1080/09546634.2019.1687828. [Epub ahead of print]

PMID:
31714168
9.

Dermatology Life Quality Index: does improving the instrument make it better?

Bashyam AM, Feldman SR.

Br J Dermatol. 2019 Nov 11. doi: 10.1111/bjd.18598. [Epub ahead of print] No abstract available.

PMID:
31709517
10.

Assessing perceived side effects of biologic medications for patients with psoriasis.

Bray JK, Cline A, Feldman SR.

J Am Acad Dermatol. 2019 Nov 7. pii: S0190-9622(19)32999-8. doi: 10.1016/j.jaad.2019.11.002. [Epub ahead of print] No abstract available.

PMID:
31706939
11.

Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis.

Frantz T, Wright EG, Balogh EA, Cline A, Adler-Neal AL, Feldman SR.

Children (Basel). 2019 Nov 5;6(11). pii: E125. doi: 10.3390/children6110125.

12.

Differences in healthcare barriers based on racial and/or ethnic background for patients with psoriasis.

Bray JK, Cline A, McMichael AJ, Feldman SR.

J Dermatolog Treat. 2019 Nov 25:1-5. doi: 10.1080/09546634.2019.1687824. [Epub ahead of print]

PMID:
31689125
13.

Comparing psoriasis advertisement methods with patient willingness to initiate treatment.

Bray JK, Cline A, Masicampo EJ, Kammrath L, Feldman SR.

J Dermatolog Treat. 2019 Nov 12:1-5. doi: 10.1080/09546634.2019.1688235. [Epub ahead of print]

PMID:
31682466
14.

Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis.

Li W, Ghamrawi R, Haidari W, Feldman SR.

Ann Pharmacother. 2019 Oct 31:1060028019885836. doi: 10.1177/1060028019885836. [Epub ahead of print]

PMID:
31672037
15.

Complementary and Integrative Therapies for Childhood Atopic Dermatitis.

Adler-Neal AL, Cline A, Frantz T, Strowd L, Feldman SR, Taylor S.

Children (Basel). 2019 Oct 30;6(11). pii: E121. doi: 10.3390/children6110121. Review.

16.

Dermatology nurses view on factors related to Danish psoriasis patients' adherence to topical drugs: a focus group study.

Svendsen MT, Feldman SR, Tiedemann SN, Stochholm Sørensen AS, Rivas CMR, Andersen KE.

J Dermatolog Treat. 2019 Nov 7:1-6. doi: 10.1080/09546634.2019.1687817. [Epub ahead of print]

PMID:
31664863
17.

Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.

Langley RGB, Reich K, Strand V, Feldman SR, Paul C, Gordon K, Warren RB, Toth D, Nikaï E, Zhu B, Goldblum O, Edson-Heredia E, Carlier H, Burge R, Lin CY, Hollister K, Augustin M.

Qual Life Res. 2019 Oct 26. doi: 10.1007/s11136-019-02296-5. [Epub ahead of print]

PMID:
31655974
18.

Publication productivity of authors of psoriasis clinical practice guidelines with and without ties to industry.

Kolli SS, Huang WW, Feldman SR.

J Am Acad Dermatol. 2019 Dec;81(6):1432-1433. doi: 10.1016/j.jaad.2019.06.001. Epub 2019 Jun 11. No abstract available.

PMID:
31611054
19.

Psoriasis patient preferences for topical drugs: a systematic review.

Svendsen MT, Feldman SR, Tiedemann SN, Sørensen ASS, Rivas CMR, Andersen KE.

J Dermatolog Treat. 2019 Oct 15:1-6. doi: 10.1080/09546634.2019.1675855. [Epub ahead of print]

PMID:
31610687
20.

How do drug shortages affect dermatologists?

Haidari W, Kolli SS, Feldman SR.

Cutis. 2019 Aug;104(2):90-91. No abstract available.

PMID:
31603957
21.

Overcoming poor adherence is a major hurdle to managing atopic dermatitis.

Strowd LC, Feldman SR.

Br J Dermatol. 2019 Sep 30. doi: 10.1111/bjd.18455. [Epub ahead of print] No abstract available.

PMID:
31571203
22.

Accountability in patient adherence.

Oussedik E, Cline A, Su JJ, Masicampo EJ, Kammrath LK, Ip E, Feldman SR.

Patient Prefer Adherence. 2019 Sep 4;13:1511-1517. doi: 10.2147/PPA.S213113. eCollection 2019.

23.

A review of topical corticosteroid sprays for the treatment of inflammatory dermatoses.

Habet KA, Kolli SS, Pona A, Feldman SR.

Dermatol Online J. 2019 Aug 15;25(8). pii: 13030/qt0855j2zz.

24.

An Increasing Trend in the Number of Publications and Research Projects Amongst Dermatology Residency Applicants.

Ezekor M, Pona A, Cline A, Huang WW, Feldman SR.

J Am Acad Dermatol. 2019 Sep 18. pii: S0190-9622(19)32758-6. doi: 10.1016/j.jaad.2019.09.021. [Epub ahead of print] No abstract available.

PMID:
31541752
25.

Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis.

Cline A, Bartos GJ, Strowd LC, Feldman SR.

Children (Basel). 2019 Sep 11;6(9). pii: E103. doi: 10.3390/children6090103. Review.

26.

Treatment decisions in psoriasis.

Visconti MJ, Bashyam AM, Feldman SR.

J Comp Eff Res. 2019 Sep;8(12):947-949. doi: 10.2217/cer-2019-0090. Epub 2019 Sep 12. No abstract available.

27.

Abnormal liver function tests in acne patients receiving isotretinoin.

Pona A, Cardenas-de la Garza JA, Haidari W, Cline A, Feldman SR, Taylor SL.

J Dermatolog Treat. 2019 Sep 9:1-4. doi: 10.1080/09546634.2019.1662882. [Epub ahead of print]

PMID:
31498706
28.

Sarecycline Review.

Haidari W, Bruinsma R, Cardenas-de la Garza JA, Feldman SR.

Ann Pharmacother. 2019 Aug 28:1060028019873111. doi: 10.1177/1060028019873111. [Epub ahead of print]

PMID:
31462063
29.

Resolution of Guttate Psoriasis Plaques After One-time Administration of Guselkumab

Hall SL, Haidari W, Feldman SR.

J Drugs Dermatol. 2019 Aug 1;18(8):822-823.

PMID:
31424714
30.

A Review of Topical Corticosteroid Foams

Payne J, Habet KA, Pona A, Feldman SR.

J Drugs Dermatol. 2019 Aug 1;18(8):756-770. Review.

PMID:
31424707
31.

Transcutaneous electrical nerve stimulation (TENS): a review of applications in dermatology.

Visconti MJ, Haidari W, Feldman SR.

J Dermatolog Treat. 2019 Aug 29:1-4. doi: 10.1080/09546634.2019.1657227. [Epub ahead of print]

PMID:
31418608
32.

Assessing the Effect of Clinical Trial Evidence and Anecdote on Caregivers' Willingness to Use Corticosteroids: A Randomized Controlled Trial.

Johnson MC, Pona A, Adler-Neal AL, Kesty C, Cline A, Feldman SR.

J Cutan Med Surg. 2019 Aug 13:1203475419871050. doi: 10.1177/1203475419871050. [Epub ahead of print]

PMID:
31409112
33.

A new spin on improving adherence.

Ramachandran V, Bashyam AM, Feldman SR.

J Dermatolog Treat. 2019 Nov;30(7):631-632. doi: 10.1080/09546634.2019.1652955. No abstract available.

PMID:
31407628
34.

Microbiome, probiotics and dermatology.

Cardenas-de la Garza JA, Haidari W, Feldman SR.

Br J Dermatol. 2019 Aug 12. doi: 10.1111/bjd.18350. [Epub ahead of print] No abstract available.

PMID:
31407325
35.

Rates of psoriasis in patients with palmoplantar pustulosis.

Haidari W, Feldman SR.

Br J Dermatol. 2019 Nov;181(5):887-888. doi: 10.1111/bjd.18314. Epub 2019 Aug 9. No abstract available.

PMID:
31399995
36.

Optimizing presentation of expected treatment outcomes.

Bray JK, Johnson MC, Masicampo EJ, Feldman SR.

J Am Acad Dermatol. 2019 Jul 26. pii: S0190-9622(19)32454-5. doi: 10.1016/j.jaad.2019.07.064. [Epub ahead of print] No abstract available.

PMID:
31351887
37.

Assessing Efficacy and the Speed of Response in Psoriasis Treatment.

Light JG, Haidari W, Feldman SR.

J Dermatolog Treat. 2019 Sep;30(6):523-524. doi: 10.1080/09546634.2019.1643588. No abstract available.

PMID:
31339413
38.

Decreased phototherapy effectiveness on lower body.

Piccinin MA, Cline A, Feldman SR.

Dermatol Online J. 2019 Jun 15;25(6). pii: 13030/qt7pg2g8zf.

39.

Cutaneous manifestations of genodermatoses and primary immunodeficiency.

Lewis DJ, Wu JH, Boyd M, Duvic M, Feldman SR.

Dermatol Online J. 2019 Jun 15;25(6). pii: 13030/qt1gj1n07j.

40.

Hidradenitis suppurativa has an enormous impact on patients' lives.

Kolli SS, Senthilnathan A, Cardwell LA, Richardson IM, Feldman SR, Pichardo RO.

J Am Acad Dermatol. 2019 Jul 12. pii: S0190-9622(19)32364-3. doi: 10.1016/j.jaad.2019.07.009. [Epub ahead of print] No abstract available.

PMID:
31302191
41.

Difference in vasoconstrictors: oxymetazoline vs. brimonidine.

Okwundu N, Cline A, Feldman SR.

J Dermatolog Treat. 2019 Aug 12:1-7. doi: 10.1080/09546634.2019.1639606. [Epub ahead of print]

PMID:
31294643
42.

The complexity of adverse event assessment and counseling for patients on biologic treatment.

Cohen SR, Pona A, Cline AE, Feldman SR.

Expert Rev Clin Immunol. 2019 Aug;15(8):809-811. doi: 10.1080/1744666X.2019.1642749. Epub 2019 Jul 12. No abstract available.

PMID:
31290340
43.

Commentary on Surgical Volume of Dermatologists Who Do Not Perform Mohs Micrographic Dermatologic Surgery.

Feldman SR, Doerfler LB.

Dermatol Surg. 2019 Jun 17. doi: 10.1097/DSS.0000000000001972. [Epub ahead of print] No abstract available.

PMID:
31211712
44.

An Evidence-Based Evaluation of Disclosure.

Chea EP, Unrue EL, Cline AE, Feldman SR.

J Dermatolog Treat. 2019 Aug;30(5):423. doi: 10.1080/09546634.2019.1629565. No abstract available.

PMID:
31195911
45.

Treatment-resistant prurigo nodularis.

Kolli SS, Haidari W, Feldman SR.

Clin Cosmet Investig Dermatol. 2019 May 9;12:345-346. doi: 10.2147/CCID.S208964. eCollection 2019. No abstract available.

46.

Tracking the price of existing biologics when drugs enter the market.

Stiff KM, Cline A, Feldman SR.

Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):375-377. doi: 10.1080/14737167.2019.1630274. Epub 2019 Jun 12. No abstract available.

PMID:
31177860
47.

Lead with your gut: research-implicated infant gut staphylococcal strains may predict development of atopic dermatitis.

Strowd LC, Feldman SR.

Br J Dermatol. 2019 Jun;180(6):1296-1297. doi: 10.1111/bjd.17732. No abstract available.

PMID:
31157427
48.

Is topical treatment effective for psoriasis in patients who failed topical treatment?

Okwundu N, Cardwell L, Cline A, Richardson I, Feldman SR.

J Dermatolog Treat. 2019 May 28:1-4. doi: 10.1080/09546634.2019.1617830. [Epub ahead of print]

PMID:
31132897
49.

Depression in hidradenitis suppurativa.

Senthilnathan A, Kolli SS, Cardwell LA, Richardson IM, Feldman SR, Pichardo RO.

Br J Dermatol. 2019 Nov;181(5):1087-1088. doi: 10.1111/bjd.18132. Epub 2019 Aug 6. No abstract available.

PMID:
31099413
50.

Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis.

Feldman SR, Pelletier CL, Wilson KL, Mehta RK, Brouillette MA, Smith D, Bonafede MM.

J Comp Eff Res. 2019 Jul;8(9):699-709. doi: 10.2217/cer-2019-0034. Epub 2019 May 13.

Supplemental Content

Loading ...
Support Center